Tech Center 1600 • Art Units: 1631 1672 1686
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17280380 | HLA SINGLE ALLELE LINES | Non-Final OA | The Broad Institute, Inc. |
| 17786061 | NEXT-GENERATION SEQUENCING DIAGNOSTIC PLATFORM AND RELATED METHODS | Non-Final OA | Ohio State Innovation Foundation |
| 19216541 | MACHINE LEARNING ENABLED ENHANCEMENT OF MOLECULAR PROPERTIES | Final Rejection | Hoffmann-La Roche Inc. |
| 19269027 | ANSWER GENERATION METHOD AND SYSTEM | Non-Final OA | LG MANAGEMENT DEVELOPMENT INSTITUTE CO., LTD. |
| 17918581 | SYSTEM FOR DETERMINING MATERIAL TO BE PROPOSED TO USER | Non-Final OA | Hitachi, Ltd. |
| 17467615 | FASTER FITTED Q-ITERATION USING ZERO-SUPPRESSED DECISION DIAGRAM | Final Rejection | INTERNATIONAL BUSINESS MACHINES CORPORATION |
| 17641909 | METHOD FOR SIMULATING OLIGOMER OR POLYMER GROWTH | Final Rejection | COVESTRO LLC |
| 17616145 | SELECTING NEOANTIGENS FOR PERSONALIZED CANCER VACCINE | Final Rejection | AMAZON TECHNOLOGIES, INC. |
| 17691761 | ANALYSIS METHOD AND ANALYZER | Final Rejection | SYSMEX CORPORATION |
| 17465424 | Systems and Methods for Detection of Aneuploidy | Non-Final OA | Natera, Inc. |
| 18505748 | UTILIZING COMPOUND-PROTEIN MACHINE LEARNING REPRESENTATIONS TO GENERATE BIOACTIVITY PREDICTIONS | Final Rejection | Recursion Pharmaceuticals, Inc. |
| 17993597 | SAMPLE CONTAMINATION DETECTION OF CONTAMINATED FRAGMENTS FOR CANCER CLASSIFICATION | Non-Final OA | GRAIL, LLC |
| 17098391 | SEIZURE DETECTION METHODS, APPARATUS, AND SYSTEMS USING A WAVELET TRANSFORM MAXIMUM MODULUS ALGORITHM | Final Rejection | FLINT HILLS SCIENTIFIC, LLC |
| 17539744 | SYSTEM AND METHOD FOR SCREENING PHENOTYPIC TARGETS ASSOCIATED WITH A DISEASE USING IN-SILICO TECHNIQUES | Final Rejection | Innoplexus AG |
| 17284357 | METHOD FOR PREDICTION OF RESPONSE TO DISEASE THERAPY | Non-Final OA | UNIVERSITÄT ROSTOCK |
| 18071786 | SYSTEMS AND METHODS FOR ANALYZING CIRCULATING TUMOR DNA | Non-Final OA | Seven Bridges Genomics Inc. |
| 17447066 | Reconstruction Algorithms for DNA-Storage Systems | Non-Final OA | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. |
| 17997448 | PATIENT STRATIFICATION USING LATENT VARIABLES | Non-Final OA | BenevolentAI Technology Limited |
| 17905682 | INTRAOPERATIVE LOCALISATION SYSTEMS AND METHODS | Non-Final OA | 360 Knee Systems Pty Ltd |
| 17400778 | METHOD FOR PREDICTING CANCER RISK VALUE BASED ON MULTI-OMICS AND MULTIDIMENSIONAL PLASMA FEATURES AND ARTIFICIAL INTELLIGENCE | Non-Final OA | SeekIn, Inc. |
| 17326060 | ASSAY SYSTEMS FOR DETERMINATION OF FETAL COPY NUMBER VARIATION | Non-Final OA | Ariosa Diagnostics, Inc. |
| 17872524 | Electronic Methods And Systems For Microorganism Characterization | Non-Final OA | FRY LABORATORIES, LLC |
| 17747365 | METHOD AND SYSTEM FOR FACILITATING PREDICTING THE THREE-DIMENSIONAL STRUCTURE OF AN AMINO ACID SEQUENCE | Non-Final OA | Armand Prieditis |
| 17732740 | Device and Method for Predicting Product Properties of Naphtha Splitting Unit | Non-Final OA | SK Incheon Petrochem Co., Ltd. |
| 17694519 | RELATIONSHIP ANALYSIS UTILIZING BIOFEEDBACK INFORMATION | Final Rejection | ONTOLEAD, INC. |
| 17577527 | PREDICTION DEVICE, TRAINED MODEL GENERATION DEVICE, PREDICTION METHOD, AND TRAINED MODEL GENERATION METHOD | Final Rejection | Ahead Biocomputing, Co. Ltd. |
| 17620669 | GENE CIRCUIT SIMULATING ARTIFICIAL NEURAL NETWORK AND CONSTRUCTION METHOD THEREFOR | Final Rejection | U Seak CHI |
| 17502309 | METHOD AND DEVICE FOR PROVIDING DRUG RECOMMENDATION | Final Rejection | Cancerfree biotech Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy